BRPI0919868B8 - processo para a preparação de um derivado de clorina ou de bacterioclorina - Google Patents
processo para a preparação de um derivado de clorina ou de bacterioclorinaInfo
- Publication number
- BRPI0919868B8 BRPI0919868B8 BRPI0919868A BRPI0919868A BRPI0919868B8 BR PI0919868 B8 BRPI0919868 B8 BR PI0919868B8 BR PI0919868 A BRPI0919868 A BR PI0919868A BR PI0919868 A BRPI0919868 A BR PI0919868A BR PI0919868 B8 BRPI0919868 B8 BR PI0919868B8
- Authority
- BR
- Brazil
- Prior art keywords
- indicated
- pdt
- pharmaceutical compositions
- methods
- bacteriochlorins
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 150000004036 bacteriochlorins Chemical class 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical compound C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 238000002560 therapeutic procedure Methods 0.000 abstract 3
- 230000003463 hyperproliferative effect Effects 0.000 abstract 2
- 238000002428 photodynamic therapy Methods 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical class [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 150000004035 chlorins Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 238000002372 labelling Methods 0.000 abstract 1
- 239000003504 photosensitizing agent Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000007910 systemic administration Methods 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0819594.3A GB0819594D0 (en) | 2008-10-24 | 2008-10-24 | Process |
GB0819594.3 | 2008-10-24 | ||
PCT/PT2009/000057 WO2010047611A1 (en) | 2008-10-24 | 2009-10-22 | Process for preparing chlorins and their pharmaceutical uses |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0919868A2 BRPI0919868A2 (pt) | 2015-12-15 |
BRPI0919868B1 BRPI0919868B1 (pt) | 2020-10-27 |
BRPI0919868B8 true BRPI0919868B8 (pt) | 2021-05-25 |
Family
ID=40133817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0919868A BRPI0919868B8 (pt) | 2008-10-24 | 2009-10-22 | processo para a preparação de um derivado de clorina ou de bacterioclorina |
Country Status (16)
Country | Link |
---|---|
US (1) | US9670217B2 (pt) |
EP (1) | EP2346874B1 (pt) |
JP (1) | JP5567024B2 (pt) |
CN (1) | CN102227432B (pt) |
AU (1) | AU2009307106B2 (pt) |
BR (1) | BRPI0919868B8 (pt) |
CA (1) | CA2741429C (pt) |
DK (1) | DK2346874T3 (pt) |
ES (1) | ES2450136T3 (pt) |
GB (1) | GB0819594D0 (pt) |
HK (1) | HK1160848A1 (pt) |
PL (1) | PL2346874T3 (pt) |
PT (1) | PT2346874E (pt) |
RU (1) | RU2513483C2 (pt) |
WO (1) | WO2010047611A1 (pt) |
ZA (1) | ZA201102760B (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8524239B2 (en) | 2010-07-09 | 2013-09-03 | The United States of America as represented by the Secrectary, Department of Health and Human Services | Photosensitizing antibody-fluorophore conjugates |
CN103781495A (zh) * | 2011-07-11 | 2014-05-07 | 美国政府(由卫生和人类服务部的部长所代表) | 光敏抗体-荧光团缀合物 |
US9371555B2 (en) | 2012-06-01 | 2016-06-21 | Concordia Laboratories Inc. | Lighting systems and methods of using lighting systems for in vitro potency assay for photofrin |
CN103721257B (zh) * | 2012-10-16 | 2016-12-21 | 无锡兆真辐射技术有限公司 | 光敏素催化分解过氧化氢系列药物 |
GB201221125D0 (en) | 2012-11-23 | 2013-01-09 | Morex Dev Partners Llp | Pharmaceutial formulations |
WO2014110149A2 (en) * | 2013-01-08 | 2014-07-17 | Stoneburner Jon F | Method of testing or treating the presence of live viruses |
AU2015300915B2 (en) | 2014-08-08 | 2020-09-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Photo-controlled removal of targets in vitro and in vivo |
AU2016238484B2 (en) | 2015-03-20 | 2020-03-19 | Luzitin, S.A. | Atropisomers of halogenated tetraphenylbacteriochlorins and chlorins and their use in photodynamic therapy |
CA2994822C (en) | 2015-08-07 | 2023-01-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Near infrared photoimmunotherapy (nir-pit) of suppressor cells to treat cancer |
CA2994871A1 (en) | 2015-08-18 | 2017-02-23 | Aspyrian Therapeutics, Inc. | Phthalocyanine dye conjugates and their storage |
CA2994849A1 (en) | 2015-08-18 | 2017-02-23 | Aspyrian Therapeutics, Inc. | Compositions, combinations and related methods for photoimmunotherapy |
WO2017051435A1 (en) * | 2015-09-22 | 2017-03-30 | Council Of Scientific And Industrial Research | Chlorin based compounds, a process for preparation thereof and use as photodynamic therapeutic agents and fluorescent probes |
US10744212B2 (en) | 2016-03-14 | 2020-08-18 | General Electric Company | Topical application of nerve labeling dyes for image-guided surgery |
WO2018065384A1 (en) * | 2016-10-03 | 2018-04-12 | Galderma Research & Development | Expression profiles of abc and slc transporters in human and minipig skin, liver and kidney |
WO2018216679A1 (ja) * | 2017-05-22 | 2018-11-29 | 国立大学法人京都大学 | テトラフェニルポルフィリン誘導体 |
CN111417400B (zh) * | 2017-09-29 | 2022-12-02 | 杜克大学 | 氟取代的卟啉化合物、包含其的药物组合物及其制备和使用方法 |
CN109912607B (zh) * | 2018-12-11 | 2021-01-22 | 南华大学 | 一类卟啉-白杨素复合物及其抗肿瘤活性 |
CN109651383B (zh) * | 2019-01-25 | 2021-11-16 | 华东理工大学 | 用于光敏剂的化合物及其应用 |
CA3138403A1 (en) * | 2019-05-20 | 2020-11-26 | Christopher J. MACNEVIN | Narrow emission dyes, compositions comprising same, and methods for making and using same |
RU2725876C1 (ru) * | 2019-07-15 | 2020-07-07 | Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) | Производные фторсодержащих хлоринов, проявляющие противоопухолевую активность |
WO2022100750A1 (zh) * | 2020-11-16 | 2022-05-19 | 北京厚燊维康科技有限责任公司 | 可用于光动力治疗或诊断的制剂 |
RU2759743C2 (ru) * | 2021-04-14 | 2021-11-17 | Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской Федерации (ФГБУ «НМИЦ радиологии» Минздрава России) | Способ комбинированного лечения локализованного t1-t2n0m0 рака гортани |
JPWO2023022187A1 (pt) * | 2021-08-18 | 2023-02-23 | ||
WO2023059180A1 (en) * | 2021-10-06 | 2023-04-13 | Tunku Abdul Rahman University Of Management And Technology (Tar Umt) | Treating skin diseases using a photodynamic therapy (pdt) and a topical agent photosensitizer formulation |
CN114813592A (zh) * | 2022-03-11 | 2022-07-29 | 华南理工大学 | 一种探究羟基氯喹在自然水体中降解机理的方法 |
CN114870011B (zh) * | 2022-03-24 | 2023-06-06 | 深圳大学 | 一种增强实体瘤内原卟啉ix蓄积的微针贴片及其制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3989816A (en) | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
US4562075A (en) | 1982-05-20 | 1985-12-31 | Nelson Research & Development Co. | Penetration enhancers for transdermal drug delivery of systemic agents |
US4405616A (en) | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
US4218803A (en) | 1979-05-25 | 1980-08-26 | Clifford Jack R | Implement for cleaning tubular culverts |
US5171741A (en) | 1989-04-21 | 1992-12-15 | Health Research, Inc. | Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
US5079262A (en) | 1989-07-28 | 1992-01-07 | Queen's University At Kingston | Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
WO1994000118A1 (en) | 1992-06-19 | 1994-01-06 | The University Of Toledo | Production and use of imines of porphyrins |
US5591847A (en) | 1994-05-23 | 1997-01-07 | Health Research, Inc. | Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages |
RU2071320C1 (ru) * | 1994-09-29 | 1997-01-10 | Акционерное общество закрытого типа Научно-производственное предприятие "Мелодит" | Сенсибилизатор для фотодинамического разрушения клеток злокачественных новообразований |
US5648485A (en) | 1994-10-26 | 1997-07-15 | University Of British Columbia | β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins |
US5770730A (en) | 1996-03-08 | 1998-06-23 | Health Research, Inc. | Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer |
JP2000007693A (ja) * | 1998-06-26 | 2000-01-11 | Lederle Japan Ltd | クロリン誘導体 |
HU228208B1 (en) | 1998-12-09 | 2013-01-28 | Yeda Res & Dev | Palladium-substituted bacteriochlorophyll derivatives and use thereof |
US6376483B1 (en) | 1999-05-27 | 2002-04-23 | Miravant Pharmaceuticals, Inc. | Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production |
US6624187B1 (en) | 2000-06-12 | 2003-09-23 | Health Research, Inc. | Long wave length absorbing bacteriochlorin alkyl ether analogs |
GB0121023D0 (en) * | 2001-08-30 | 2001-10-24 | Norwegian Radium Hospital Res | Compound |
PT102721B (pt) | 2002-02-01 | 2011-01-24 | Cipan Companhia Industr Prod De Antibioticos S A | Compostos macrocíclicos tetrapirrólicos com rendimento quântico de oxigénio singuleto adequado à terapia fotodinâmica e processos para a sua preparação |
WO2004002476A2 (en) | 2002-06-27 | 2004-01-08 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
FR2877943B1 (fr) | 2004-11-16 | 2008-09-05 | Univ De Coimbra | Nouveaux derives de porphyrine, notamment chlorines et/ou bacteriochlorine, et leurs applications en therapie photodynamique |
WO2006089122A2 (en) | 2005-02-18 | 2006-08-24 | North Carolina State University | De novo synthesis of bacteriochlorins |
EP2123664A1 (en) | 2007-02-19 | 2009-11-25 | Rei Medical Co., Ltd. | Novel sugar-linked chlorin derivative and process for production thereof |
-
2008
- 2008-10-24 GB GBGB0819594.3A patent/GB0819594D0/en not_active Ceased
-
2009
- 2009-10-22 CN CN200980147426.7A patent/CN102227432B/zh active Active
- 2009-10-22 JP JP2011533133A patent/JP5567024B2/ja active Active
- 2009-10-22 CA CA2741429A patent/CA2741429C/en active Active
- 2009-10-22 PT PT97682553T patent/PT2346874E/pt unknown
- 2009-10-22 BR BRPI0919868A patent/BRPI0919868B8/pt not_active IP Right Cessation
- 2009-10-22 DK DK09768255.3T patent/DK2346874T3/en active
- 2009-10-22 WO PCT/PT2009/000057 patent/WO2010047611A1/en active Application Filing
- 2009-10-22 RU RU2011114878/04A patent/RU2513483C2/ru active
- 2009-10-22 AU AU2009307106A patent/AU2009307106B2/en not_active Ceased
- 2009-10-22 ES ES09768255.3T patent/ES2450136T3/es active Active
- 2009-10-22 US US13/125,805 patent/US9670217B2/en active Active
- 2009-10-22 EP EP09768255.3A patent/EP2346874B1/en active Active
- 2009-10-22 PL PL09768255T patent/PL2346874T3/pl unknown
-
2011
- 2011-04-13 ZA ZA2011/02760A patent/ZA201102760B/en unknown
-
2012
- 2012-02-08 HK HK12101197.5A patent/HK1160848A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2741429A1 (en) | 2011-04-29 |
CA2741429C (en) | 2017-04-18 |
ES2450136T3 (es) | 2014-03-24 |
CN102227432A (zh) | 2011-10-26 |
JP2012506425A (ja) | 2012-03-15 |
WO2010047611A1 (en) | 2010-04-29 |
AU2009307106B2 (en) | 2015-05-07 |
JP5567024B2 (ja) | 2014-08-06 |
RU2011114878A (ru) | 2012-11-27 |
EP2346874A1 (en) | 2011-07-27 |
GB0819594D0 (en) | 2008-12-03 |
WO2010047611A9 (en) | 2010-07-22 |
CN102227432B (zh) | 2015-04-22 |
US20110250143A1 (en) | 2011-10-13 |
EP2346874B1 (en) | 2013-12-04 |
BRPI0919868A2 (pt) | 2015-12-15 |
BRPI0919868B1 (pt) | 2020-10-27 |
AU2009307106A1 (en) | 2010-04-29 |
HK1160848A1 (en) | 2012-08-17 |
ZA201102760B (en) | 2012-07-25 |
PT2346874E (pt) | 2014-03-06 |
RU2513483C2 (ru) | 2014-04-20 |
DK2346874T3 (en) | 2014-03-03 |
PL2346874T3 (pl) | 2014-05-30 |
US9670217B2 (en) | 2017-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0919868B8 (pt) | processo para a preparação de um derivado de clorina ou de bacterioclorina | |
Zhang et al. | Switchable PDT for reducing skin photosensitization by a NIR dye inducing self-assembled and photo-disassembled nanoparticles | |
Xing et al. | Multifunctional divalent vancomycin: the fluorescent imaging and photodynamic antimicrobial properties for drug resistant bacteria | |
Bredell et al. | The application and challenges of clinical PD–PDT in the head and neck region: A short review | |
Wang et al. | Induction of cytotoxicity by photoexcitation of TiO 2 can prolong survival in glioma-bearing mice | |
US8506931B2 (en) | Perylenequinone derivatives and uses thereof | |
Xu et al. | Combination of photodynamic therapy with radiotherapy for cancer treatment | |
Zhou et al. | Advances in photosensitizer-related design for photodynamic therapy | |
Negri et al. | Photobiomodulation combined with photodynamic therapy using ruthenium phthalocyanine complexes in A375 melanoma cells: Effects of nitric oxide generation and ATP production | |
Cheng et al. | A Facile, Protein‐Derived Supramolecular Theranostic Strategy for Multimodal‐Imaging‐Guided Photodynamic and Photothermal Immunotherapy In Vivo | |
BRPI0212172B1 (pt) | Agente fotossensibilizante, processo para a preparação de um agente fotossensibilizante, composição farmacêutica, usos de um agente fotossensibilizante ou de um sal farmaceuticamente aceitável do mesmo, e de um agente fotossensibilizante ou de um sal farmaceuticamente aceitável do mesmo e de uma molécula de transferência, métodos para a introdução de uma molécula de transferência no citosol de uma célula in vitro e para diagnose in vitro de anormalidades ou distúrbios através da análise de uma amostra de fluido ou tecido do corpo de um paciente, produto, e, kit para uso em fotoquimioterapia de distúrbios ou anormalidades de superfícies externas ou internas do corpo | |
Huang et al. | Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy | |
WO2008133664A3 (en) | Carboranylporphyrins and uses thereof | |
Liu et al. | Supramolecular organic frameworks improve the safety of clinically used porphyrin photodynamic agents and maintain their antitumor efficacy | |
WO2013048022A3 (ko) | 수용해도 및 수분산성이 향상된 α-형태의 아연-프탈로시아닌 나노와이어, α-형태의 아연-프탈로시아닌 나노와이어/페노티아진 복합체, 및 이의 제조방법 | |
Xiong et al. | Photo-controllable biochemistry: Exploiting the photocages in phototherapeutic window | |
Liu et al. | A distinctive spinach‐based carbon nanomaterial with chlorophyll‐rich and near‐infrared emission for simultaneous in vivo biothiol imaging and dual‐enhanced photodynamic therapy of tumor | |
Wang et al. | Folic Acid–Conjugated Pyropheophorbide a as the Photosensitizer Tested for In Vivo Targeted Photodynamic Therapy | |
US20210361702A1 (en) | Fluoro substituted porphyrin compounds, pharmaceutical compositions comprising the same, and methods of preparing and using the same | |
Mazraedoost et al. | Nano materials-based devices by photodynamic therapy for treating cancer applications | |
BR112013001576A2 (pt) | composto tetrapirrólico e composição farmacêutica derivado farmacêuticamente aceitável da mesma e respectivos usos e métodos de terapia fotodinâmica e de diagnóstico e tratamento da artrite e de doenças inflamatórias semelhantes. | |
Wong et al. | Phthalaldehyde-amine capture reactions for bioconjugation and immobilization of phthalocyanines | |
US20130226136A1 (en) | Molecules for the Photodynamic Treatment of Tumors and Hyperplasias | |
Chen et al. | Recent advances in developing photosensitizers for photodynamic cancer therapy | |
Serda et al. | Synthesis and applications of [60] fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/10/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/10/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 14A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2745 DE 15-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |